van den Brink H R, van Everdingen A A, van Wijk M J, Jacobs J W, Bijlsma J W
Department of Rheumatology, University Hospital Utrecht, The Netherlands.
Ann Rheum Dis. 1993 Dec;52(12):862-5. doi: 10.1136/ard.52.12.862.
To investigate whether oestrogens can be used as treatment to diminish disease activity in women with rheumatoid arthritis.
Forty postmenopausal female patients with active rheumatoid arthritis participated in a placebo-controlled, double-blind study on the possible beneficial effect of adjuvant treatment of oestradiol on disease activity.
Thirty three patients completed 52 weeks of treatment with 2 mg oestradiol-valerate or placebo. No statistically significant difference was found in and between both treatment groups with regard to articular indices, pain score by visual analogue scale, erythrocyte sedimentation rate and health questionnaire on daily activities before, during and at the end of the study.
This first randomised prospective placebo-controlled study shows no beneficial effect of oestrogens on disease activity in postmenopausal female patients with rheumatoid arthritis.
研究雌激素是否可用于减轻类风湿关节炎女性患者的疾病活动度。
40名患有活动性类风湿关节炎的绝经后女性患者参与了一项关于雌二醇辅助治疗对疾病活动度可能有益作用的安慰剂对照双盲研究。
33名患者完成了为期52周的2mg戊酸雌二醇或安慰剂治疗。在研究前、研究期间和研究结束时,两个治疗组在关节指数、视觉模拟评分法疼痛评分、红细胞沉降率和日常活动健康问卷方面均未发现统计学上的显著差异。
这项首次随机前瞻性安慰剂对照研究表明,雌激素对绝经后类风湿关节炎女性患者的疾病活动度没有有益作用。